Dante Genomics
Hereditary Cancer Panel
Hereditary Cancer Panel
The Dante Hereditary Cancer Panel conducts targeted analysis of 31 well-known oncogenes, ensuring highly efficient detection of variants linked to hereditary cancer. This comprehensive solution analyzes clinically relevant genes with high coverage, delivering results quickly and affordably.
Next Generation Sequencing
Next generation sequencing is a valuable and powerful method to assess risk of developing a wide range of hereditary cancers, including: breast, ovary, uterus, prostate, and gastrointestinal malignancies and the probability that such predispositions can be transmitted to future generations.
Main Advantages
- Cost-effective
- Superior sensitivity and specificity
- Higher sequencing depths in the target regions
- Accurate CNV analysis and detection of SNV and INDEL
- Provides information for HRD grade computation
- Short Turnaround times
- User-friendly customizable solutions
Bioinformatic Features
- Primary Analysis (FASTQ)
- Secondary Analysis (VCF, annotation, CNV and Large InDel reporting)
- Tertiary Analysis (Clinical interpretation)